MYX mayne pharma group limited

I'm not talking about Yaz. And, I am not saying it won't sell....

  1. 203 Posts.
    lightbulb Created with Sketch. 109
    I'm not talking about Yaz. And, I am not saying it won't sell. You are suggesting B2B 250% revenue growth. If anyone with any investment capital actually believed this as well they would be accumulating. Which is just not the case.

    Nextstellis was priced and sold to investors as a game changer. It is obvious that this isn't the case and it has similar side effects from its competitors. It is just another player in a well serviced market.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$5.03
Change
-0.170(3.27%)
Mkt cap ! $408.6M
Open High Low Value Volume
$5.20 $5.21 $5.03 $2.804M 555.6K

Buyers (Bids)

No. Vol. Price($)
2 14654 $5.03
 

Sellers (Offers)

Price($) Vol. No.
$5.14 3111 2
View Market Depth
Last trade - 16.10pm 20/06/2025 (20 minute delay) ?
MYX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.